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(related to Figure 1 and Supplemental Experimental Procedures) Figure S2 (related to Figure 1 and Table S1) Figure S3 (related to Figure 1 and Table S1) Figure S4 (related to Figure 3 ) Figure S5 (related to Figures 4 and 7) Figure S6 (related to Figures 5 and 6) Figure S7 (related to Figure 7 ) Table S1 (related to Figures 1, S2 , and S3) Table S2 (related to Figure 7 ) Table S3 (related to Figures 1-7) Table S4 ( Sections of sEBs and representative immunofluorescence analysis showing NKX2.1-GFP, PAX6, FOXG1, and NKX2.2 expression. Blue: DAPI. Scale Bar: 100 m. Additional immunostaining analysis of sEB sections showed induction of the ventral telencephalic markers OLIG2 and ASCL1 (early), ISLET1 (late), and mitotic marker KI67 (throughout). The migratory neuronal marker, DCX, and GABA were induced over time. In contrast, the hypothalamic marker, RAX, and the cholinergic neuronal marker, CHAT, were not detected after 50 days of differentiation. Blue=DAPI. (A) Dendrogram clustering analysis of microarray data identified the d20, d35, and d55 GFP+ populations to be more closely related to each other than to the undifferentiated hPSCs. (B) Quantitative RTPCR analysis of undifferentiated hPSCs (black bars) and 3-week GFP+ cells (blue bars) relative to GAPDH expression. Data represented as mean SD.
(C-F) Additional markers from microarray analysis. Legend: undifferentiated hPSC (black), d20 GFP+ (blue), d35 GFP+ (orange), and d55 GFP+ (green) samples. Panels show: hypothalamic (C), cortical excitatory neuronal lineage (D), ventral telencephalic (E), and general fetal developmental markers (F). GP=globus pallidus, POA=pre-optic area, Sep=septum, PN=projection neuron. Hypothalamic and cortical excitatory neuronal markers were not detected, aside from temporary NKX2.2 transcript expression at early stages. The POA/Sep, GP, and MGE-derived PN markers, ETV1 and GBX2, were also not detected. The dorsal MGE and CGE marker, NR2F2 (COUPTFII), was identified at a low level, consistent with rare GFP+ cells expressing COUPTFII protein ( Figure 3E ), and NKX62 was also weakly detected at d20. The early embryonic markers, DPPA4, LIN28, and LIN28B, have been used to estimate the developmental stage of neural cells derived from human pluripotent stem cells (Patterson et al., 2012) . In human fetal spinal cord, LIN28 expression is downregulated by 7gw, whereas DPPA4 and LIN28B are not reduced until 13gw. In our cultures, DPPA4 and LIN28 were not detected by d35, and LIN28B expression persisted to d55. These results suggest d35-55 GFP+ cells may be similar to a 7-13gw fetal developmental stage. Data represented as mean SEM. To promote neuronal differentiation prior to transplantation, hPSC-derived cultures were either replated at a low density, pulsed with DAPT, or FACS sorted for PSANCAM expression. FACS sorting for NKX2.1-GFP expression was performed in all protocols. Sorting for PSANCAM+ cells eliminated tumor incidence postinjection. Tumors were defined as human nuclei+ and KI67+ growths at the injection site that persisted for more than three months post-injection. 
Figure S5. Development of Interneuron Subtypes in Human FetaltoInfant
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Supplemental Experimental Procedures
Development of the B27+5F Method
We compared four published protocols (methods #1, 2, 3, and 4) for their ability to induce NKX2.1+ cells from hPSCs. The first method (#1) reported hESC-derived NKX2.1+ and FOXG1+ cells at ~13% efficiency (Watanabe et al., 2007) . This 35-day protocol utilized serum-free (knockout serum replacement (KSR)-early/B27-late) supplemented medias and dual-SMAD inhibition of BMP (via BMPRIA-Fc) and activin/nodal (via SB431542) signaling pathways to direct neural ectoderm-like differentiation, along with WNT pathway inhibition (via DKK1) to specify anterior forebrain-like identity of embryoid bodies (EBs). From day 24-35, inhibitors were removed, and sonic hedgehog (SHH) was added to specify ventroanterior forebrainlike cells. The second method (#2) reported NKX2.1+ and FOXG1+ cells at ~84% efficiency after 28 days in serum-free (KSR/N2) supplemented medias (Li et al., 2009 ). Dual-SMAD inhibition was not used, but SHH treatment, with or without simultaneous WNT inhibition, was initiated earlier during differentiation (day 10-28). Although these protocols were reported to generate FOXG1+ and NKX2.1+ cells, ventral telencephalic MGE-like versus POA/septum-like identity was not investigated.
In our hands, method #1 ( Figure S1B ), method #2 (not shown), and an optimized version of method #1 ( Figure S1A ) were unable to generate NKX2.1-GFP+ cells. The same was true when SHH was used instead of purmorphamine. However, we found that a hybrid method could generate NKX2.1-GFP+ cells at 12% efficiency as quantified by fluorescence activated cell sorting (FACS) ( Figure S1C ). This 25-day hybrid method involved dual-SMAD (via SB431542 and BMPRIA-Fc) and WNT (via DKK1) inhibition throughout the protocol and simultaneous Smoothened agonist, purmorphamine, treatment from day 10-25 in serum-free (KSR/B27) supplemented medias. A similar efficiency was achieved in B27/B27 supplemented media (not shown). We assumed that GFP+ cell induction resulted from early (d10) SHH pathway activation, in contrast to late (d24) SHH from method #1, and we hypothesized that even earlier addition of purmorphamine (from day 0-25) would increase the percentage of NKX2.1+ cells. However, this modification resulted in decreased (1.9%) efficiency in KSR/B27 media ( Figure S1D ).
However, replacing KSR with B27 supplemented media throughout the 25day protocol, along with early addition of five factors [Rho-associated protein kinase (ROCK) inhibitor (Y27632), dual-SMAD inhibitors (SB431542 and BMPRIA-Fc), WNT inhibitor (DKK1), and Smoothened agonist (purmorphamine)], surprisingly resulted in most cells (70.2%) becoming NKX2.1GFP+ ( Figure S1E ). Furthermore, when the inhibitors were removed after two weeks of differentiation, and the protocol extended to day 35, we achieved NKX2.1GFP+ differentiation efficiencies up to 90.8% by FACS analysis (Figure S1F ). Thus, early activation of the SHH pathway in combination with B27, or lack of KSR, media (B27+5F method) directed efficient ventral forebrain-like differentiation from hESCs.
During this study, a third method (method #3) reported to direct hypothalamic forebrain-like differentiation from HES-3 NKX2.1 GFP/w hESCs at 12-14% efficiency in the presence of FGF2 and retinoic acid (Goulburn et al., 2011) . SHH was not used, but the media appeared to induce SHH, and WNT inhibitor, expression in their cultures and promoted a ventro-anterior neural fate despite use of retinoic acid, which can act as a caudalizing agent. After 50 days, some cells expressed FOXG1, but the efficiency and fates of these cells were not determined. In our hands, method #3 generated GFP+ cells at ~7% efficiency. In line with hypothalamic-like identity, method #3 generated less NKX2.1+ expression and more NKX2.2+ cells on day 24 compared to the B27+5F method (data not shown). Lastly, we also evaluated an alternative dual-SMAD inhibition method reported to generate anterior telencephalic-like progenitors, but we were unable to detect NKX2.1 expression (Chambers et al., 2009) . SHH pathway activation was required for NKX2.1-GFP+ cell derivation. In this study, we used 1-2µM of purmorphamine or 500ng/mL of SHH. Although 2-6µM of purmorphamine slightly increased GFP+ differentiation efficiency in EB cultures, these higher concentrations decreased the viability of later-stage monolayer cultures (not shown). We also investigated whether WNT inhibition was dispensable for hESC-telencephalic-like identity, as suggested previously (Li et al., 2009 ). While GFP+ cell differentiation efficiency was similar, DKK1 WNT inhibitor absence resulted in a decrease in the number of cells expressing telencephalic FOXG1 from 70% to 45% (not shown). In addition to WNTs, FGFs act as important rostro-caudal patterning factors during neural development (Borello et al., 2008; Mason, 2007; Ye et al., 1998) , and FGF8 has been implicated in MGE telencephaliclike development from mouse ESCs (Danjo et al., 2011) . We did not add FGF8 to our cultures, but we did detect FGF8 transcript expression, in agreement with its role downstream of SHH (Gutin et al., 2006; Ohkubo et al., 2002) . Addition of an FGF inhibitor (PD173074) from the onset of differentiation (d0-25) caused a decrease in cells expressing FOXG1 (55%), but addition of the same inhibitor on day 14 (d14-25) had no effect on FOXG1 levels (not shown). Therefore, similar to fetal forebrain development, early inhibition of WNT and activation of FGF signaling pathways, along with SHH activation, play roles in patterning the ventral-telencephalic-like identity of hPSC-derived cultures.
Cost-effective cell production methods will be preferred over lengthy protocols and expensive recombinant protein-based reagents, and cryopreservation of cells will facilitate future work. Here, we used 3 small molecules (Y27632, SB431542, and purmorphamine) and 2 recombinant proteins (BMPRIA-Fc and DKK1). Several small molecule substitutes now exist for inhibition of BMP and WNT pathways. We found that dorsomorphin (BMP pathway inhibitor) and CKI-7 (WNT pathway inhibitor) could replace the proteins in the B27+5F method (Kim et al., 2010; Osakada et al., 2009) . Although cell viability was reduced by ~50%, NKX2.1-GFP+ efficiency was comparable (not shown). In addition, ~25% of hESC-derived MGE-like cells were viable after cryopreservation and thawing, and thawed cells matured into neurons with functional properties as confirmed by electrophysiology.
For future clinical transplantation, unmodified GMP-grade hPSC lines will be required. Accordingly, we examined cGMP-matched hESC lines (ESI17, ESI35, ESI51, and ESI53 (Biotime)) for their ability to generate NKX2.1+ MGE-like cells. All of the lines were similar to HES-3 in NKX2.1+ differentiation efficiency using the B27+5F method (not shown). Since the clinical grade lines do not have the NKX2.1 knock-in reporter, future work will need to determine acceptable impurity thresholds. Perhaps 75% purity of hPSC-derived NKX2.1+ cells will be sufficient, particularly if the remaining impurities represent non-MGE-type GABAergic interneurons. Suggesting this possibility, we observed that most HES3 NKX2.1-GFPnegative neurons expressed GABA, and some expressed TH, but none expressed TBR1 or CHAT excitatory neuronal markers. If 100% NKX2.1+ MGE-like purity is required for safety and efficacy, then alternative solutions may be explored such as development of antibodies to MGE-specific cell surface markers, or use of nonintegrating virus to deliver MGE-or interneuron-specific fluorescent reporters (Potter et al., 2009) , for FACS-based purification.
Transplantation and Graft Proliferation
Initially, day 35 monolayer cultures were sorted for NKX2.1-GFP+, without PSA-NCAM selection, and injected into newborn SCID mouse cortex. However, within 4 months, injected mouse brains (12/12 mice) contained tumor-like overgrowths at the injection site and/or at the pial surface near the injection tract (data not shown). These were not pluripotent cell-derived teratomas; OCT4+ cells or polarized neuroepithelial rosettes were not found. The growths primarily contained NKX2.1-GFP+ neural cells. Tumors were defined as a core of human-specific nuclear antigen (HNA) positive and KI67+ human cells persisting for more than 3 months postinjection (MPI). Initially, tumor incidence was a surprise because day 35 cultures contained seemingly few neural progenitor cells expressing KI67, GFAP, or OLIG2 ( Figure 3E ). But, focal growths (~1 focus/2500 plated cells, n=3) were occasionally detected in extended co-cultures, consistent with tumor formation in vivo. Therefore, we performed protocol optimization to impede these growths. Lowdensity monolayer culture promoted neuronal differentiation and lowered tumor incidence to 50% (6/12 mice). Tumor incidence was further reduced to 33% (3/9 mice) by brief addition of DAPT, a gamma secretase inhibitor of Notch signaling, to induce neuronal differentiation prior to injection. In vitro focal growths (n=3) and in vivo tumor incidence were eliminated (0/6 mice) when day 35 cultures were pretreated with DAPT and FACS-sorted for both NKX2.1-GFP+ and PSA-NCAM+ cells prior to co-culture or transplantation, whereas GFP+ and PSA-NCAM-negative cells continued to form foci and tumors (3/4 mice). However, the percentage of injected human cells expressing interneuron subtype markers was reduced compared to in vitro maturation co-cultures. Therefore, additional protocol optimization was performed. We found that extending the 3-dimensional adherent EB culture out to day-50 ( Figure 1B and 7A) , without dissociation or monolayer culture, followed by FACS purification for NKX2.1-GFP+ and PSA-NCAM+ cells resulted in both the absence of tumors (0/7 mice) and increased subtype marker expression (4/4 mice) by 6 MPI. A summary of injected animals is provided (Table S2) .
Cell Culture and FACS Sorting
On ~d7, Y27632 was removed, and sEBs were plated adherent en-bloc onto matrigel (BD Biosciences) coated plates in medium #1. On ~d14, factors were removed from medium #1 except for Purmorphamine. On ~d25, aEBs were trypsinized and replated as dissociated monolayer onto matrigel or polyornithine/laminin coated plates. DAPT (10µM) (Tocris) was added from ~d27-d30. After FACS sorting on ~day 35, GFP+ cells could be replated (10-25,000 cells/cm 2 ) onto cortical glial cells in medium #1. Glial cells were prepared from newborn mouse cortex, passaged at least 3X with serum to remove mouse neurons, and pre-treated at confluency with Ara-C (5µM) (Sigma). Every 3-4 days, half of media was replaced with differentiation medium #2: Neurobasal-A, 2% B27+vitaminA, (Invitrogen) and same supplements in medium #1, without factors, except NEAA and Purmorphamine were removed, and BDNF (25ng/mL) was added (R&D Systems). Media was replaced every 3-4 days.
FACS analysis and sorting was performed on FACSAria II (BD Biosciences). Cells were gated for live cell DAPI exclusion, small scatter size, single cells, NKX2.1-GFP signal, and PSA-NCAM-APC or -PE (Miltenyi Biotech) signal intensity. GFPnegative cells and isotype antibody (Santa Cruz) controls were used. Data was analyzed with Flowjo (Treestar) software.
For live cell imaging, differentiation was similar to above, but 5,000 cells/well were plated into Aggrewell-800 plates (Stem Cell Technologies), and sEBs were plated en-bloc on day 4-7. Imaging was performed by time-lapse confocal microscopy with temperature (37°C) and gas (5% O2, 5% CO2, 90% N2) controls (Leica SP5).
Second trimester human fetal cortex or MGE tissue was dissected, dissociated to single cells with Papain (Worthington Biochemical), plated onto matrigel coated plates (~100,000 cells/cm 2 ) in differentiation medium #2, and treated with Ara-C at confluence. MGE cells cultured for one week, or hESCs sorted on day 35, were replated onto cortical cultures (~10-20,000 cells/cm 2 ).
Lentivirus Preparation
Self-inactivating lentiviral plasmids, FUGW-UbC-RFP (RFP dimer2) or pLenti-Synapsin-hChR2(H134R)-EYFP-WPRE (kind gift from Karl Deisseroth), were cotransfected with delta8.9 and VSVG plasmids into 293T cells (ATCC). Lentiviral particle supernatants were collected, concentrated by ultracentrifugation, and used to transduce cells overnight with 8µg/mL polybrene (Millipore).
Electrophysiology and Optical Methods
For cultured neurons, the bath was constantly perfused with fresh recording medium containing (in mM): 145 NaCl, 3 KCl, 3 CaCl2, 2 MgCl2, 10 HEPES, 8 glucose. Transverse slices (300 µm) were cut on a tissue chopper (Leica VT1200S) and maintained in an incubation chamber with aCSF containing (in mM): 110 Choline Cl, 2.5 KCl, 0.5 CaCl 2 , 7 MgCl 2 , 1.3 NaH 2 PO 4 , 25 NaHCO 3 , 10 glucose. Slice recording medium contained (in mM): 125 NaCl, 2.5 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 1.3 NaH 2 PO 4 , 25 NaHCO 3 , 10 glucose. Recordings were made with an Axon 700B patch-clamp amplifier and 1320A interface (Axon Instruments). Signals were filtered at 2 kHz using amplifier circuitry, sampled at 10 kHz, and analyzed using Clampex 10.2 (Axon Instruments).
Photostimulation was delivered by mercury lamp (75 mW) with a GFP excitation bandpass filter and light pulses were generated by Maste-8 (A.M.P.I.) through a high-speed shutter (UNIBLITZ), the power density of the blue light
